查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
定序試劑市場規模、佔有率及成長分析（按試劑類型、定序技術、應用、最終用戶及地區分類）－2025-2032年產業預測
市場調查報告書
商品編碼
1865221

定序試劑市場規模、佔有率及成長分析（按試劑類型、定序技術、應用、最終用戶及地區分類）－2025-2032年產業預測

Sequencing Reagents Market Size, Share, and Growth Analysis, By Reagent Type, By Sequencing Technology (Next-Generation Sequencing, Sanger Sequencing), By Application, By End-User, By Region - Industry Forecast 2025-2032
出版日期: | 出版商: SkyQuest | 英文 174 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

預計到 2023 年，全球定序試劑市場規模將達到 82 億美元，到 2024 年將成長至 96.6 億美元，到 2032 年將成長至 358.2 億美元，預測期（2025-2032 年）的複合年成長率為 17.8%。

全球定序定序市場預計將迎來顯著成長，這主要得益於次世代定序(NGS) 技術的日益普及和精準醫療需求的不斷成長。隨著醫療專業人員擴大利用基因組數據進行包括腫瘤學和罕見疾病研究在內的各種應用，定序試劑的需求預計將大幅提升。此外，基因測序在農業、環境監測和微生物組研究等領域的廣泛應用也創造了新的機會。技術進步正在降低定序成本並提高其可及性，從而進一步提升供應商的收入前景。然而，高成本、數據分析複雜、倫理問題以及不同平台之間的相容性問題等挑戰，可能會在短期內阻礙市場滲透。

全球定序試劑市場促進因素

全球定序試劑市場的主要促進因素之一是對個人化醫療日益成長的需求，而個人化醫療高度依賴基因組數據來客製化治療方案。隨著醫療保健向精準醫療發展，對準確且高效的定序技術的需求不斷成長，推動了定序試劑的進步。此外，遺傳疾病的日益普遍以及定序技術在腫瘤學、藥物基因組學和感染疾病控制等領域的廣泛應用，也進一步推動了市場發展。這些因素，加上持續不斷的研發投入，不斷提升定序試劑的性能和可近性，促進了其在全球的廣泛應用。

限制全球定序試劑市場發展的因素

全球定序試劑市場的主要限制因素之一是先進定序技術及其試劑本身的高成本。研究和臨床應用所需的大量資金投入可能會阻礙小型實驗室和機構採用這些技術。此外，嚴格的監管要求以及有效使用定序試劑所需的專業人員也進一步增加了這些機構進入市場的難度。這種高准入門檻可能會限制創新和取得尖端定序解決方案，最終減緩整體市場成長，並阻礙其在各種研究和臨床環境中的廣泛應用。

全球定序試劑市場趨勢

全球定序試劑市場正呈現單細胞和空間基因組學應用日益成長的顯著趨勢。試劑產業的企業正致力於條碼化學技術的進步和擴增效率的提升，同時優先考慮污染控制，以滿足研究人員的特殊需求。這項轉變的驅動力在於對超靈敏、低起始量試劑的需求不斷成長，這些試劑能夠檢測細微的基因表現和突變，從而推動個人化醫療和疾病研究的突破。因此，市場呈現成長態勢，定序技術的創新正在塑造其未來的發展模式。

目錄

介紹

  • 調查目標
  • 調查範圍
  • 定義

調查方法

  • 資訊收集
  • 二手資料和一手資料方法
  • 市場規模預測
  • 市場假設與限制

執行摘要

  • 全球市場展望
  • 供需趨勢分析
  • 細分市場機會分析

市場動態與展望

  • 市場概覽
  • 市場規模
  • 市場動態
    • 促進因素和機遇
    • 限制與挑戰
  • 波特分析

關鍵市場考察

  • 關鍵成功因素
  • 競爭程度
  • 關鍵投資機會
  • 市場生態系統
  • 市場吸引力指數（2024）
  • PESTEL 分析
  • 總體經濟指標
  • 價值鏈分析
  • 定價分析
  • 技術評估
  • 監管環境

按試劑類型定序試劑市場規模及複合年成長率（2025-2032 年）

  • 市場概覽
  • 樣品製備套件
  • 模板套件
  • 控制和品質保證套件
  • 定序套件
  • 其他（富集試劑套件、索引/條碼試劑）

依定定序技術分類的定序試劑市場規模及複合年成長率（2025-2032 年）

  • 市場概覽
  • 次世代定序（NGS）
  • 桑格定序
  • 第三代定序（TGS）/長讀長定序

依應用領域定序試劑市場規模及複合年成長率（2025-2032 年）

  • 市場概覽
  • 腫瘤學/液態生物檢體
  • 生殖醫學/產前檢查
  • 臨床診斷
  • 研究/學術基因組學
  • 農業、法醫學等。

依最終用戶定序試劑市場規模及複合年成長率（2025-2032 年）

  • 市場概覽
  • 醫院和臨床實驗室
  • 製藥和生物技術公司
  • 學術和研究機構
  • 受託研究機構（CRO）

定序試劑市場規模及複合年成長率（2025-2032）

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 西班牙
    • 法國
    • 英國
    • 義大利
    • 其他歐洲地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲地區
  • 中東和非洲
    • 海灣合作理事會國家
    • 南非
    • 其他中東和非洲地區

競爭資訊

  • 前五大公司對比
  • 主要企業的市場定位（2024 年）
  • 主要市場參與者所採取的策略
  • 近期市場趨勢
  • 公司市佔率分析（2024 年）
  • 主要企業簡介
    • 公司詳情
    • 產品系列分析
    • 依業務板塊進行公司股票分析
    • 2022-2024年營收年比比較

主要企業簡介

  • Illumina, Inc.
  • Thermo Fisher Scientific Inc.
  • QIAGEN NV
  • Oxford Nanopore Technologies plc
  • Pacific Biosciences of California, Inc.
  • F. Hoffmann La Roche AG
  • Agilent Technologies, Inc.
  • Takara Bio Inc.
  • BD（Becton, Dickinson and Company）
  • Meridian Bioscience Inc.
  • Fluidigm Corporation
  • BGI Genomics
  • Illumina Cambridge Ltd
  • Myriad Genetics, Inc.
  • ArcherDX, Inc.
  • Eurofins Scientific SE
  • PerkinElmer, Inc.
  • Bio Rad Laboratories, Inc.
  • Takara Holdings Inc.
  • Beijing Genomics Institute（BGI）

結論與建議

簡介目錄
Product Code: SQMIG35H2383

Global Sequencing Reagents Market size was valued at USD 8.2 billion in 2023 and is poised to grow from USD 9.66 billion in 2024 to USD 35.82 billion by 2032, growing at a CAGR of 17.8% during the forecast period (2025-2032).

The global sequencing reagents market is poised for significant growth, driven by the increasing adoption of next-generation sequencing (NGS) technologies and the rising demand for precision medicine. As healthcare professionals increasingly utilize genomic data for various applications, including oncology and rare disease research, the demand for sequencing reagents is expected to surge. Moreover, the expanding use of genomic sequencing in agriculture, environmental monitoring, and microbiome studies presents new opportunities. Advances in technology are also leading to reduced sequencing costs and improved accessibility, further enhancing revenue prospects for providers. However, challenges such as high reagent costs, complex data analysis, ethical concerns, and compatibility issues with different platforms may hinder market penetration in the foreseeable future.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Sequencing Reagents market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Sequencing Reagents Market Segments Analysis

Global Sequencing Reagents Market is segmented by Reagent Type, Sequencing Technology, Application, End-User and region. Based on Reagent Type, the market is segmented into Library Preparation Kits, Template Kits, Control & Quality Assurance Kits, Sequencing Kits and Others (enrichment kits, indexing/barcoding reagents). Based on Sequencing Technology, the market is segmented into Next-Generation Sequencing (NGS), Sanger Sequencing and Third-Generation Sequencing (TGS) / Long-Read Sequencing. Based on Application, the market is segmented into Oncology & Liquid Biopsy, Reproductive Health / Prenatal Testing, Clinical Diagnostics, Research / Academic Genomics and Agriculture, Forensics & Others. Based on End-User, the market is segmented into Hospitals & Clinical Laboratories, Pharmaceutical & Biotechnology Companies, Academic & Research Institutes and Contract Research Organizations (CROs). Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Sequencing Reagents Market

One of the key market drivers for the global sequencing reagents market is the increasing demand for personalized medicine, which relies heavily on genomic data for tailored treatment approaches. As healthcare shifts towards precision medicine, the need for accurate and efficient sequencing technologies grows, prompting advancements in sequencing reagents. Additionally, the rising prevalence of genetic disorders and the expansion of applications in areas such as oncology, pharmacogenomics, and infectious disease management further fuel the market. These factors, combined with ongoing research and development initiatives, continue to enhance the capabilities and accessibility of sequencing reagents, driving their widespread adoption globally.

Restraints in the Global Sequencing Reagents Market

One significant market restraint in the global sequencing reagents market is the high cost associated with advanced sequencing technologies and the reagents themselves. The substantial financial investment required for research and clinical applications can deter smaller laboratories and institutions from adopting these technologies. Additionally, stringent regulatory requirements and the necessity for specialized personnel to effectively utilize sequencing reagents further complicate market entry for these entities. This high barrier to entry may limit innovation and access to cutting-edge sequencing solutions, ultimately slowing down the overall growth of the market and hindering widespread implementation across diverse research and clinical settings.

Market Trends of the Global Sequencing Reagents Market

The Global Sequencing Reagents market is witnessing a significant trend towards the expansion of single-cell and spatial genomics applications. Companies in the reagents sector are increasingly focusing on advancing barcoding chemistries and enhancing amplification efficiency, while also prioritizing contamination control to cater to the specialized demands of researchers. This shift is driven by the rising necessity for ultra-sensitive and low-input reagents capable of detecting subtle gene expressions and mutations, thereby enabling breakthroughs in personalized medicine and disease research. As a result, the market is poised for growth, with innovations in sequencing technologies shaping its future landscape.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Technology Assessment
  • Regulatory Landscape

Global Sequencing Reagents Market Size by Reagent Type & CAGR (2025-2032)

  • Market Overview
  • Library Preparation Kits
  • Template Kits
  • Control & Quality Assurance Kits
  • Sequencing Kits
  • Others (enrichment kits, indexing/barcoding reagents)

Global Sequencing Reagents Market Size by Sequencing Technology & CAGR (2025-2032)

  • Market Overview
  • Next-Generation Sequencing (NGS)
  • Sanger Sequencing
  • Third-Generation Sequencing (TGS) / Long-Read Sequencing

Global Sequencing Reagents Market Size by Application & CAGR (2025-2032)

  • Market Overview
  • Oncology & Liquid Biopsy
  • Reproductive Health / Prenatal Testing
  • Clinical Diagnostics
  • Research / Academic Genomics
  • Agriculture, Forensics & Others

Global Sequencing Reagents Market Size by End-User & CAGR (2025-2032)

  • Market Overview
  • Hospitals & Clinical Laboratories
  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Contract Research Organizations (CROs)

Global Sequencing Reagents Market Size & CAGR (2025-2032)

  • North America (Reagent Type, Sequencing Technology, Application, End-User)
    • US
    • Canada
  • Europe (Reagent Type, Sequencing Technology, Application, End-User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Reagent Type, Sequencing Technology, Application, End-User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Reagent Type, Sequencing Technology, Application, End-User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Reagent Type, Sequencing Technology, Application, End-User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • Illumina, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Thermo Fisher Scientific Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • QIAGEN N.V.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Oxford Nanopore Technologies plc
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Pacific Biosciences of California, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • F. Hoffmann La Roche AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Agilent Technologies, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Takara Bio Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BD (Becton, Dickinson and Company)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Meridian Bioscience Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Fluidigm Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BGI Genomics
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Illumina Cambridge Ltd
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Myriad Genetics, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ArcherDX, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Eurofins Scientific SE
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • PerkinElmer, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bio Rad Laboratories, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Takara Holdings Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Beijing Genomics Institute (BGI)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations